[CYCC] YoY Quarter Result on 31-Dec-2014 [#Q4]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
31-Mar-2015
Financial Year
2014
Quarter
31-Dec-2014 [#Q4]
Profit Trend
QoQ- 2.20%
YoY- -34.84%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 0 277 424 247 299 5 175 -
PBT -2,071 -3,249 -3,872 -5,907 -4,026 -5,067 -3,780 -9.53%
Tax -200 -409 -498 -1,108 -452 -637 -122 8.57%
NP -1,871 -2,839 -3,374 -4,799 -3,559 -4,764 -3,658 -10.56%
Tax Rate - - - - - - - -
Total Cost 1,871 3,116 3,798 5,046 3,858 4,769 3,833 -11.25%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin 0.00 -1,024.91 -795.75 -1,942.91 -1,190.30 -95,280.00 -2,090.29 -
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS -3.14 -13.34 -23.15 -50.11 -44.87 -149.01 -113.25 -44.95%
EPS Diluted -3.12 -13.34 -23.15 -50.11 -44.87 -149.01 -112.22 -44.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.